Abstract 4287: GBC-11004: an AI-driven novel kinase target with potential to overcome osimertinib resistance in NSCLC
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-4287
Abstract: Osimertinib resistance poses a significant clinical challenge in the treatment of non-small cell lung cancer (NSCLC), with diverse mechanisms complicating patient outcomes. Conventional next-generation sequencing (NGS) analysis methods often fall short in identifying effective therapeutic… read more here.
Keywords: resistance nsclc; gbc 11004; target; osimertinib resistance ... See more keywords